These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 19458885)
21. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hsu YH; Niu T; Terwedow HA; Xu X; Feng Y; Li Z; Brain JD; Rosen CJ; Laird N; Xu X Hum Genet; 2006 Jan; 118(5):568-77. PubMed ID: 16249885 [TBL] [Abstract][Full Text] [Related]
22. Gene Polymorphisms in the RANKL/RANK/OPG Pathway Are Associated with Type 2 Diabetes Mellitus in Southern Han Chinese Women. Duan P; Tu P; Si L; Hu W; Liu M; Liu J; Xue Y Genet Test Mol Biomarkers; 2016 Jun; 20(6):285-90. PubMed ID: 27171030 [TBL] [Abstract][Full Text] [Related]
23. Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study. Assmann G; Pfoehler C; Simon P; Pfreundschuh M; Tilgen W; Wieczorek S J Dermatol; 2011 Jun; 38(6):519-23. PubMed ID: 21352301 [TBL] [Abstract][Full Text] [Related]
24. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis. Yang H; Liu W; Zhou X; Rui H; Zhang H; Liu R Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31209146 [TBL] [Abstract][Full Text] [Related]
25. SNPs in the vicinity of P2X7R, RANK/RANKL/OPG and Wnt signalling pathways and their association with bone phenotypes in academy footballers. Varley I; Hughes DC; Greeves JP; Fraser WD; Sale C Bone; 2018 Mar; 108():179-185. PubMed ID: 29325759 [TBL] [Abstract][Full Text] [Related]
26. Association of Variant Interactions in Chen B; Du Z; Dong X; Li Z; Wang Q; Chen G; Zhang G; Song Y DNA Cell Biol; 2019 Jul; 38(7):734-746. PubMed ID: 31149839 [TBL] [Abstract][Full Text] [Related]
27. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head]. Wang J; Wang K; Shi Z; Zhang M Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868 [TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. Zavala-Cerna MG; Moran-Moguel MC; Cornejo-Toledo JA; Gonzalez-Montoya NG; Sanchez-Corona J; Salazar-Paramo M; Nava-Zavala AH; Aguilar-Chavez EA; Alcaraz-Lopez MF; Gonzalez-Sanchez AG; Gonzalez-Lopez L; Gamez-Nava JI J Immunol Res; 2015; 2015():376197. PubMed ID: 26065000 [TBL] [Abstract][Full Text] [Related]
29. Association of gene polymorphisms in RANKL/RANK/OPG system with hypertension and blood pressure in Chinese women. Duan P; Wang ZM; Liu J; Wang LN; Yang Z; Tu P J Hum Hypertens; 2015 Dec; 29(12):749-53. PubMed ID: 25810067 [TBL] [Abstract][Full Text] [Related]
30. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH). Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721 [TBL] [Abstract][Full Text] [Related]
31. RANK/RANKL/OPG pathway: genetic associations with stress fracture period prevalence in elite athletes. Varley I; Hughes DC; Greeves JP; Stellingwerff T; Ranson C; Fraser WD; Sale C Bone; 2015 Feb; 71():131-6. PubMed ID: 25464125 [TBL] [Abstract][Full Text] [Related]
32. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. Duan P; Wang ZM; Liu J; Wang LN; Yang Z; Tu P BMC Womens Health; 2015 Apr; 15():32. PubMed ID: 25884698 [TBL] [Abstract][Full Text] [Related]
33. Association of Genes Variants in RANKL/RANK/OPG Signaling Pathway with the Development of Osteonecrosis of the Femoral Head in Chinese Population. Song Y; Du ZW; Yang QW; Ren M; Wang QY; Wang A; Chen GY; Zhao HY; Yu T; Zhang GZ Int J Med Sci; 2017; 14(7):690-697. PubMed ID: 28824302 [TBL] [Abstract][Full Text] [Related]
34. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway. Mencej-Bedrač S; Zupan J; Mlakar SJ; Zavratnik A; Preželj J; Marc J Drug Metabol Drug Interact; 2014; 29(2):111-4. PubMed ID: 24615483 [TBL] [Abstract][Full Text] [Related]
35. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study. Stern A; Laughlin GA; Bergstrom J; Barrett-Connor E Eur J Endocrinol; 2007 May; 156(5):555-62. PubMed ID: 17468191 [TBL] [Abstract][Full Text] [Related]
37. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. Zupan J; Komadina R; Marc J J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539 [TBL] [Abstract][Full Text] [Related]
38. The Relationship between Serum and Gene Expression Levels of RANK, RANKL and Osteoprotegerin Inflammatory Pathway with Unstable Angina: A Case-control Study. Farrokhian A; Miraftab M; Chenari M; Akbari H; Nikoueinejad H; Naimi E Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):473-483. PubMed ID: 34418901 [TBL] [Abstract][Full Text] [Related]
39. Association of OPG and RANKL gene polymorphisms with bone mineral density in Indian women. Nair S; Bhadricha H; Patil A; Surve S; Joshi B; Balasinor N; Desai M Gene; 2022 Oct; 840():146746. PubMed ID: 35868414 [TBL] [Abstract][Full Text] [Related]
40. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans]. Kobayashi Y; Takahashi N Clin Calcium; 2008 Feb; 18(2):202-9. PubMed ID: 18245890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]